// App-Quantinova.ai

BS19 : Phosphodiesterase 1 (PDE1) inhibition enhances prostacyclin mediated signalling in pulmonary artery smooth muscle cells through a novel selective pde1c:prostacyclin receptor interaction

Researchers

Presenter

  • Zaher Al Bakour

Principal Investigators

  • James Hislop

  • James Guy Breitenbucher

  • Fiona Murray

Medical Centers

  • University of Aberdeen, Aberdeen, UK

  • Convelo Therapeutics

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Cyclic adenosine monophosphate

Drug/Treatment

  • Prostacyclin

  • chloroquine

  • Selexipag

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved